Verena M Wagner

Summary

Country: Germany

Publications

  1. ncbi request reprint Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial -- a large-scale multicentre study
    Verena M Wagner
    Department of Paediatrics, University Hospital Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:73-9. 2005
  2. ncbi request reprint Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus
    Verena M Wagner
    Klinik fur Kinder und Jugendmedizin, Universtätsklinikum Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:491-6. 2005
  3. ncbi request reprint Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs--a follow-up report of a large multicenter database
    Verena M Wagner
    Department of Pediatrics, University Clinic Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Eur J Pediatr 167:241-2. 2008
  4. doi request reprint Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy
    Verena M Wagner
    Department of Pediatrics, Division of Pediatric Endocrinology and Diabetology, University of Lubeck, Lubeck, Germany
    Eur J Pediatr 168:359-61. 2009

Detail Information

Publications4

  1. ncbi request reprint Severe hypoglycaemia, metabolic control and diabetes management in children with type 1 diabetes in the decade after the Diabetes Control and Complications Trial -- a large-scale multicentre study
    Verena M Wagner
    Department of Paediatrics, University Hospital Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:73-9. 2005
    ..Significant predictors of hypoglycaemia were younger age ( P <0.0001), longer diabetes duration ( P <0.0001), higher insulin dose/kg per day ( P <0.0001), injection regimen ( P <0.0005), and centre experience ( P <0.05)...
  2. ncbi request reprint Age, metabolic control and type of insulin regime influences health-related quality of life in children and adolescents with type 1 diabetes mellitus
    Verena M Wagner
    Klinik fur Kinder und Jugendmedizin, Universtätsklinikum Schleswig Holstein, Campus Lubeck, Ratzeburger Allee 160, 23538 Lubeck, Germany
    Eur J Pediatr 164:491-6. 2005
    ..05). The subscale "chronic illness" showed a better HRQOL (P < 0.001) in children and adolescents with diabetes compared to age-matched controls with other chronic conditions...
  3. ncbi request reprint Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs--a follow-up report of a large multicenter database
    Verena M Wagner
    Department of Pediatrics, University Clinic Schleswig Holstein, Campus Lubeck, Lubeck, Germany
    Eur J Pediatr 167:241-2. 2008
  4. doi request reprint Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2--initial and long-term response to sulfonylurea therapy
    Verena M Wagner
    Department of Pediatrics, Division of Pediatric Endocrinology and Diabetology, University of Lubeck, Lubeck, Germany
    Eur J Pediatr 168:359-61. 2009
    ..2 are the most frequent cause of diabetes in infancy. Sulfonylurea (SU) treatment restores insulin secretion in patients with KCNJ11 mutations...